.
New from McKinsey & Company | | COVID-19: Where we've been, where we are, and where we're going | When lockdowns began in early 2020, few of us imagined the long road ahead. While progress in protecting lives and livelihoods was swift, new variants and other factors have since meant that there have been times when the virus has seemed to be one step ahead of every countermeasure. Today, some of the biggest issues revolve around the pandemic’s knock-on effects: on talent, supply chains, inclusive growth, and more. Dive deeper with these curated reads for a look back—and a lens on what’s next—and explore all our articles on COVID-19 in our special collection on emerging stronger from the pandemic. | | | | | When will the COVID-19 pandemic end? | After the short, sharp shock of Omicron, the pandemic phase of COVID-19 looks to be ending for most locations, unless a significant and severe new variant emerges. This update discusses what we've learned from Omicron, the prospects for the rest of 2022, and presents three potential criteria for defining COVID-19 as endemic. | Navigate new developments | | | | To see more essential reading on topics that matter, visit McKinsey Themes. | — Curated by Eleni Kostopoulos, a digital publishing manager based in New York | McKinsey Insights - Get our latest thinking on your iPhone, iPad, or Android | | | | This email contains information about McKinsey’s research, insights, services, or events. By opening our emails or clicking on links, you agree to our use of cookies and web tracking technology. For more information on how we use and protect your information, please review our privacy policy. | You received this email because you subscribed to our Strategy alert list. | | Copyright © 2022 | McKinsey & Company, 3 World Trade Center, 175 Greenwich Street, New York, NY 10007 | | | |
No comments:
Post a Comment